The INSPIRE-Lung Study

Description

LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.

Conditions

Lung Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.

Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations

The INSPIRE-Lung Study

Condition
Lung Cancer
Intervention / Treatment

-

Contacts and Locations

Nutley

Hackensack Meridian Health - Center for Discovery and Innovation, Nutley, New Jersey, United States, 07110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ≥20-pack-year smoking history;
  • * Individuals who currently smoke or quit smoking within the past 15 years
  • * Previously undergone LDCT for early detection of lung cancer, have a lung nodule or nodules that are currently being followed
  • * Has ever been diagnosed with lung cancer
  • * Individuals with impaired decision-making (because our primary outcome is decision-making, we will not include individuals with impaired decision-making)

Ages Eligible for Study

50 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Hackensack Meridian Health,

Lisa Carter-Bawa, PhD, PRINCIPAL_INVESTIGATOR, Hackensack Meridian Health

Study Record Dates

2027-07-30